4
Total deals
$109.3M
Total value
$27.3M
Avg deal
$90.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Artegraft
Artegraft offers surgeons a biological alternative to synthetic grafts.
|
2020-06-22 | Acquisition | Complete | $90.0M | Deal → |
| 2 |
Restore Flow Allografts
Restore Flow Allografts is dedicated to researching the restorative transplantat…
|
2016-11-10 | Acquisition | Complete | $14.0M | Deal → |
| 3 |
Inavein
Founded in 2007, InaVein's mission is to develop and commercialize a family of i…
|
2013-08-28 | Acquisition | Complete | $2.5M | Deal → |
| 4 |
Vascular Architects
Vascular Architects are develops and markets devices to treat vascular disease a…
|
2007-09-20 | Acquisition | Complete | $2.8M | Deal → |